Skip to content

6-KAccepted Apr 24, 4:22 PM ET

Agomab Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:22 PM

Apr 24, 2026

Filed

Apr 24, 2026

Documents

22

Size

2.9 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.